Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-09

FDA Approved: LEVETIRACETAM — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a generic formulation of levetiracetam from Micro Labs Limited under ANDA211954.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)